CCO Oncology Podcast

189 Episodo

1. BRCA Testing and Adjuvant Therapy in Early Breast Cancer: Experiences and Challenges

   Publicado: 5/4/2023
2. Experts Discuss Claudin 18.2: A New Target for Precision Care of Gastric and Gastroesophageal Cancers

   Publicado: 28/3/2023
3. Treatment Considerations for Patients With Essential Thrombocythemia: A Conversation Between Experts

   Publicado: 23/2/2023
4. FAQs on the Use of Asparaginase Therapy in Young and Older Adults With Acute Lymphoblastic Leukemia

   Publicado: 20/2/2023
5. Experts Answer Questions on the Management of Patients With T-Cell Lymphomas

   Publicado: 17/2/2023
6. Experts Answer Questions on Personalized Management of Patients With Myelodysplastic Syndromes

   Publicado: 17/2/2023
7. Individualizing Care for Patients With Triple-Negative Breast Cancer

   Publicado: 18/1/2023
8. Contemporary Approaches to Treating Polycythemia Vera: A Conversation Between Experts

   Publicado: 11/1/2023
9. HCC Surveillance: Challenges and Opportunities

   Publicado: 3/1/2023
10. A Patient’s Perspective on Effective Communication With the Healthcare Team: My Journey With High-Risk HR-Positive/HER2-Negative Early Breast Cancer

    Publicado: 13/12/2022
11. Expert Thoughts on Studies of Interest Presented at the 2022 ESGO Annual Meeting on Gynecologic Cancers

    Publicado: 29/11/2022
12. The Transgender Cancer Experience: A Conversation Between an Oncologist and a Transmasculine Individual on Navigating the Healthcare System

    Publicado: 29/11/2022
13. Evolving Role of BTK Inhibitors in CLL: Experts Answer Your Questions

    Publicado: 9/11/2022
14. New Evidence With BTK Inhibitor Therapy in CLL and MCL From the SOHO 2022 Annual Meeting

    Publicado: 28/10/2022
15. Expert Thoughts on Key Trials of Interest for Ovarian and Cervical Cancer at the IGCS 2022 Annual Global Meeting

    Publicado: 24/10/2022
16. Relapsed/Refractory Myeloma: Navigating the Complex Treatment Landscape

    Publicado: 24/10/2022
17. Expert Insights on Key Updates From the 2022 ESMO Congress on PARP Inhibitors in Ovarian Cancer

    Publicado: 4/10/2022
18. Managing EGFR-Mutated Non-Small-Cell Lung Cancer in Today’s Clinic: Expert Answers to Frequently Asked Questions

    Publicado: 28/9/2022
19. New Evidence With BTK Inhibitor Therapy in CLL and MCL From the Pan Pacific Lymphoma Conference 2022

    Publicado: 30/8/2022
20. Experts Discuss Challenges in Advanced Hepatocellular Carcinoma Management

    Publicado: 22/8/2022